Ingredient · Evidence grade C-
Probiotics for menopause: evidence, studies and safety
Last updated · 3 studies summarized
C- Short answer: Probiotics support digestive health*. Only one strain (L. acidophilus YT1) has a menopause-symptom trial, and it is not in any product we ranked; effects on bone are mixed.
Key facts
| Evidence grade | C- C- (symptoms, 1 RCT); C (bone, mixed) |
|---|---|
| Use studied | menopausal symptoms; bone |
| Trials | 1 symptom RCT (n=67); 12 bone RCTs (1,183) |
| Participants | ~1,250 |
| What reviews conclude | Bone MA (Wang 2024) positive BMD; 2-year L. reuteri RCT (n=239) null. |
| The Menopause Society (2023) | L. acidophilus YT1 not recommended (Level II). |
| Also known as | Lactobacillus acidophilus YT1, MENOLACTO |
Grades: A strong · B moderate · C limited · D none or negative. How we grade.
Every study we reviewed
Each summary gives who took part, the dose, how long, the result compared with placebo or control, and who paid for it.
-
The Effect of Lactobacillus acidophilus YT1 (MENOLACTO) on Improving Menopausal Symptoms: A Randomized, Double-Blinded, Placebo-Controlled Clinical Trial.
67 Korean women took a specific probiotic strain or placebo for 12 weeks; overall menopause scores improved. It is the only trial of its kind and NAMS did not recommend it.
- Who
- 67 women (Korea)
- Dose
- Lactobacillus acidophilus YT1 (MENOLACTO) 1×10^8 CFU/day
- Duration
- 12 weeks
- Result
- Kupperman Index and MENQOL improved vs placebo; no hormone or endometrial changes.
- Funding
- Authors declared no conflicts. Independent / academic
-
Limosilactobacillus reuteri 6475 and Prevention of Early Postmenopausal Bone Loss: A Randomized Clinical Trial.
239 Swedish women took a probiotic or placebo for 2 years. The probiotic did not slow bone loss.
- Who
- 239 early-postmenopausal women
- Dose
- Limosilactobacillus reuteri 6475 (2 doses)
- Duration
- 2 years
- Result
- No effect on bone loss or bone turnover vs placebo.
- Funding
- Industry partner BioGaia (strain owner) per paper (not verified in abstract); independent stats. Industry-linked
-
Effects of probiotic supplementation on bone health in postmenopausal women: a systematic review and meta-analysis.
Pooling 12 trials, probiotics were linked to slightly better bone density in postmenopausal women, though the largest single trial was negative.
- Who
- 12 RCTs, 1,183 women
- Dose
- various probiotics
- Duration
- various
- Result
- Higher spine (SMD 0.60) and hip BMD (SMD 0.74) vs control.
- Funding
- Academic (China). Independent / academic
Safety
Generally safe; strain-specific.
Ranked products that contain it
| Product | Amount per day | Score | $/day |
|---|---|---|---|
| MenoLabs MenoFit | Probiotic blend (4 strains, 25 billion CFU): 96 mg | 46.3 | $1.67 |
| Stripes The Inside Addition | Bacillus coagulans 200 million CFU: amount not disclosed Lactobacillus sp. 1 billion CFU: amount not disclosed | 43.5 | $1.67 |
| BB Company Provitalize | Synbiotic probiotic blend (L. gasseri SBT2055 + 2 strains): 400 mg | 40.5 | $1.77 |
FAQ
Does Probiotics help with menopause symptoms?
Probiotics support digestive health*. Only one strain (L. acidophilus YT1) has a menopause-symptom trial, and it is not in any product we ranked; effects on bone are mixed. Our evidence grade is C- (symptoms, 1 RCT); C (bone, mixed). Bone MA (Wang 2024) positive BMD; 2-year L. reuteri RCT (n=239) null.
Does The Menopause Society recommend Probiotics?
L. acidophilus YT1 not recommended (Level II). The 2023 nonhormone statement recommends no dietary supplement for hot flashes; talk to a clinician about hormone therapy and prescription options.
Is Probiotics safe?
Generally safe; strain-specific. Supplements are not FDA-approved before sale; ask a clinician or pharmacist, especially if you take medication.
Sources
*These statements have not been evaluated by the Food and Drug Administration. These products are not intended to diagnose, treat, cure, or prevent any disease. Solynes does not sell supplements; descriptions summarize published research and are not medical advice.